Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jun 15;4(2):219-25.
doi: 10.3889/oamjms.2016.043. Epub 2016 May 24.

Hepatitis B Seroprotection and the Response to a Challenging Dose among Vaccinated Children in Red Sea Governorate

Affiliations

Hepatitis B Seroprotection and the Response to a Challenging Dose among Vaccinated Children in Red Sea Governorate

Samia M Sami et al. Open Access Maced J Med Sci. .

Abstract

Aim: To assess the long-term effectiveness of hepatitis B virus vaccine and the need for a booster dose among children who received three doses of vaccine during infancy in Red Sea Governorate.

Methods: A cross-sectional study was performed. Interviews with children (9 months to 16 years) and parents were done. Blood samples to assess Hepatitis B markers were tested. Children showing no seroprotection received a booster dose to assess their anamnestic response after four weeks and one year later.

Results: None of the participants had evidence of chronic Hepatitis B. The seroprotection rate was 23.3% and it significantly decreased with age. Multivariate logistic analysis revealed that older age was the significant predicting variable for having no seroprotective level, while baseline anti-HBs level < 3.3 IU/L was the predicting variable for not developing early anamnestic response or loss of late anamnestic response.

Conclusion: Long-term immunity persists among children who received complete series of hepatitis B vaccination during infancy even in absence or reduction of anti-HBs over time. Therefore, a booster dose is not necessary to maintain immunity till the age of sixteen.

Keywords: Anamnestic response; Booster dose; Children; Egypt; HBV vaccine; Seroprotection.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Baseline seroprotection and early anamnestic response rates among the studied children.

References

    1. Huang C, Dai C, Chuang W, Ho C, Wu T, Hou N, Wang C, Hsieh M, Huang J, Lin Z, Chen S, Hsieh M, Wang L, Tsai J, Chang W, Yu M. Preventive Medicine. Vol. 48. Elsevier Inc; 2009. HBV infection in indigenous children, 20 years after immunization in Taiwan: A community-based study; pp. 397–400. http://dx.doi.org/10.1016/j.ypmed.2009.02.002 . PMid: 19463479. - PubMed
    1. World Health Organization (WHO) Hepatitis B.1. Geneva: WHO Fact sheet No. 204; [accessed 18 May 2009]. http://www.who.int/mediacentre/factsheets/fs204/en/index.html .
    1. Talaat M, El-Sayed N, Kandeel A, Azab MA, Afifi S, Youssef FG, Ismael T, Hajjeh R, Mahoney FJ. Sentinel surveillance for patients with acute hepatitis in Egypt 2001–04. Eastern Mediterranean Health Journal (EMHJ) 2010;16:2. - PubMed
    1. Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP. Hepatitis B Virus Infection: Epidemiology and Vaccination. From the Epidemiology Branch, Division of Viral Hepatitis, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA. Accepted for publication March 28. 2006
    1. Han K, Shao X, Zheng H, Wu C, Zhu J, Zheng X, Zhang Y. Revaccination of non- and low- responders after a standard three dose hepatitis B vaccine schedule. Human Vaccines & Immunotherapeutics. 2012;8(12):1845–1849. http://dx.doi.org/10.4161/hv.21818 . PMid: 22906933 PMCid: PMC3656074. - PMC - PubMed

LinkOut - more resources